PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients

2014-01-22
(Press-News.org) Contact information: Sam Smith
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients ROCHESTER, Minn. ― Jan. 21, 2014 ― Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, just as it has for breast cancer. The study is published in this month's Modern Pathology.

As with breast cancer, HER2 amplification in MPUC results in a faster growing form of cancer that spreads quickly and has a higher chance of recurrence. The hope is that combating this amplification with trastuzumab, a drug that is effective in HER2 positive breast cancers, will result in effective therapy against bladder cancer.

"These findings show it is critical for pathologists to recognize this type of bladder cancer and that providers order the appropriate tests," says John Cheville, M.D., a Mayo Clinic pathologist and lead author of the study. "This will be essential for any clinical trial examining the effectiveness of trastuzmab in treating MPUC."

The study identified HER2 amplification in 15 percent of patients with MPUC, compared to 9 percent of typical bladder cancers. Patients with HER2-amplified MPUC were more likely to have aggressive tumors than patients whose tumors did not have HER2 amplification, according to this study.

"Targeted treatments for HER2 positive breast cancer have led to markedly improved survival," says Dr. Cheville. "In one sense, what we are trying to do with HER2 positive bladder cancer is a relatively simple thing. We are trying to identify prognostic and therapeutic biomarkers, and ultimately match the most effective drug to the individual patient's tumor, rather than its location in the body."

HER2 is a very important target in breast cancer therapy, and gene amplification occurs in approximately 20–30 percent of cases, says Dr. Cheville. Using the latest molecular techniques, researchers in the Mayo Clinic Center for Individualized Medicine's Biomarker Discovery Program determined that some bladder cancers similarly show HER2 amplification and produce too much of the HER2 protein product, resulting in more rapid tumor growth and expansion.

This type of individualized therapy represents the future of cancer care, and findings like the one reported in Modern Pathology are only the beginning of many more to come, Dr. Cheville says. Last year, the Biomarker Discovery Program identified and validated 12 different molecular/genomic markers, most of them related to the diagnosis, treatment and prognosis of a variety of cancers.

### About Mayo Clinic Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, http://www.mayoclinic.org and newsnetwork.mayoclinic.org.

About the Mayo Clinic Center for Individualized Medicine The Center for Individualized Medicine discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for each Mayo Clinic patient. Visit http://mayoresearch.mayo.edu/center-for-individualized-medicine for more information.


ELSE PRESS RELEASES FROM THIS DATE:

X-ray diffraction technique 'maps' strain and crack propagation in metallic tubing

2014-01-22
X-ray diffraction technique 'maps' strain and crack propagation in metallic tubing A team of researchers exploring the intergranular stress corrosion cracking of a type of metallic tubing used within nuclear power plants has developed a technique to both map and ...

3-D imaging provides window into living cells, no dye required

2014-01-22
3-D imaging provides window into living cells, no dye required CHAMPAIGN, Ill. — Living cells are ready for their close-ups, thanks to a new imaging technique that needs no dyes or other chemicals, yet renders high-resolution, three-dimensional, ...

New avenue to treat diabetes-related vision problems

2014-01-22
New avenue to treat diabetes-related vision problems Eye on dopamine Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, researchers have discovered. The ...

No-till soybean fields give (even some rare) birds a foothold in Illinois

2014-01-22
No-till soybean fields give (even some rare) birds a foothold in Illinois CHAMPAIGN, Ill. — Researchers report in a new study that several bird species – some of them relatively rare – are making extensive use of soybean fields in Illinois. The team ...

Live feed into our bodies

2014-01-22
Live feed into our bodies A palm-top device developed by UCSB researchers provides real-time insight into how fast a living body metabolizes drugs, opening the door to highly personalized medicine (Santa Barbara, Calif.) — A device that ...

Sedentary behavior and low physical activity linked to heart failure in men

2014-01-22
Sedentary behavior and low physical activity linked to heart failure in men PASADENA, CALIF., 21, 2014 — Men who reported being sedentary with low levels of physical activity were at a significantly higher risk for heart failure than those who were more active, ...

Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder

2014-01-22
Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder A St. Jude Children's Research Hospital study found that despite being diagnosed with life-threatening illnesses, childhood cancer patients are no more likely than ...

Subterranean 'sedimentary bathtub' amplifies earthquakes

2014-01-22
Subterranean 'sedimentary bathtub' amplifies earthquakes A basin of stiff soil beneath Vancouver might make earthquakes there more severe than expected, a San Diego State University seismologist finds SAN DIEGO, Calif. (Jan. 21, 2014)— Like an amphitheater amplifies ...

Emergency treatment takes longer for heart attack victims during off-hours

2014-01-22
Emergency treatment takes longer for heart attack victims during off-hours ROCHESTER, Minn. — Jan. 21, 2014 — More people die and emergency hospital treatment takes longer for heart attack victims who arrive at the hospital during off-hours (nights and weekends), compared ...

White, green or black roofs? Berkeley Lab report compares economic payoffs

2014-01-22
White, green or black roofs? Berkeley Lab report compares economic payoffs Looking strictly at the economic costs and benefits of three different roof types—black, white and "green" (or vegetated)—Lawrence Berkeley National Laboratory (Berkeley Lab) ...

LAST 30 PRESS RELEASES:

In US, saving money is top reason to embrace solar power

Antibiotic pollution in rivers

Join the nation of lifesavers at NFL draft in Green Bay

TTUHSC researchers seek novel therapies for chronic pain

Predicting long-term psychedelic side-effects

Carnegie Mellon researchers create transformable flat-to-shape objects using sewing technology

Preventing cellular senescence to prevent neuroinflammation

Tuning in to blood glucose for simpler early diabetes detection

NUS Medicine and HeyVenus study: Menopause is a critical workplace challenge for APAC business leaders

Insects are disappearing due to agriculture – and many other drivers, new research reveals

Blends of child and best friend, with power imbalance: How dogs fit into our social networks

Transgene-free genome editing in poplar trees: A step toward sustainable forestry

Single-dose psychedelic boosts brain flexibility for weeks, peer-reviewed study finds

Sex differences drive substance use patterns in panic disorder patients

Multi-omics meets immune profiling in the quest to decode disease risk

Medication-induced sterol disruption: A silent threat to brain development and public health

Shining a light on DNA: a rapid, ultra-sensitive, PCR-free detection method

European hares are thriving in the city: New monitoring methods reveal high densities in Danish urban areas

Study: middle-aged Americans are lonelier than adults in other countries, age groups

World’s leading science competition identifies 19 breakthrough solutions around the globe with greatest potential to tackle the planetary crisis

Should farm fields be used for crops or solar? MSU research suggests both

Study: Using pilocarpine drops post goniotomy may reduce long-term glaucoma medication needs

Stanford Medicine researchers develop RNA blood test to detect cancers, other clues

Novel treatment approach for language disorder shows promise

Trash talk: As plastic use soars, researchers examine biodegradable solutions

Using ChatGPT, students might pass a course, but with a cost

Psilocibin, or “magic mushroom,” use increased among all age groups since decriminalization in 2019

More Americans are using psilocybin—especially those with mental health conditions, study shows

Meta-analysis finds Transcendental Meditation reduces post-traumatic stress disorder (PTSD) symptoms across populations and cultures

AACR: Five MD Anderson researchers honored with 2025 Scientific Achievement Awards

[Press-News.org] Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients